Smartphones have gotten good enough to provide nearly continuous, closed-loop, outpatient control of blood sugar in people with diabetes, according to a recently published study.
Boris Kovatchev and fellow researchers from three countries first presented their findings of this attempt to make the “artificial pancreas” mobile at the American Diabetes Association’s annual scientific meeting in June and had their work published in the July edition of the journal Diabetes Care.
The Juvenile Diabetes Research Foundation, which funded the research along with the National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases, defines the artificial pancreas as automated closed-loop control of blood glucose.
Prior to this study, artificial pancreas tests had employed laptops wired to continuous glucose monitors and insulin pumps. The paper called this “a system limiting free movement and too cumbersome to be used beyond hospital confines.”